Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Myomo Inc.

MYONYSE_AMERICANEQUITYCurrent

Notice of Proposed Sale

Filed Jul 13, 2026Accepted Jul 13, 2026, 4:29 PM EDTFiling CIK 1195842Accession 0001193125-26-302069
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
MYOMO, INC.
Issuer CIK
0001369290
SEC file number
001-38109
Phone
617-996-9058
Person for whose account securities are to be sold
David Henry
Relationships to issuer
Officer
Street
45 Blue Sky Dr.
Street (continued)
Suite 101
City
Burlington
State / country code
MA
Postal code
01803

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common Stock5,1665,630.9438,638,66907/13/2026NYSE AmericanMorgan Stanley

Broker / market maker — proposed row 1, entry 1

Name
Morgan Stanley
Street
1 New York Plaza
Street (continued)
38th Floor
City
New York
State / country code
NY
Postal code
10004

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common Stock07/09/2026Vesting of Restricted Stock UnitsMyomo, Inc.12,500N07/09/2026Vesting of Restricted Stock Units

Sales reported in the preceding three months

Sales reported in the preceding three months · 1 reported row
SellerSecuritySale dateAmount soldGross proceeds
David HenryCommon Stock04/13/20263,9532,806.60

Seller — prior-sale row 1, entry 1

Name
David Henry
Street
45 Blue Sky Dr.
Street (continued)
Suite 101
City
Burlington
State / country code
MA
Postal code
01803

Prior-sale reporting

Nothing to report for the preceding three months
N

Remarks

Shares being sold on July 13, 2026 solely to pay income taxes on the vesting of restricted stock units on July 9, 2026, pursuant to a irrevocable election by the Reporting Party on December 11, 2025.

Notice signature

Notice date
07/13/2026
Signed
/s/ David Henry

Company context

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

Current securities

Recent company filings

  1. 4 filingOct 15, 2026
  2. 4 filingOct 15, 2026
  3. 4 filingOct 13, 2026
  4. 4 filingOct 13, 2026
  5. 144 filingOct 13, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.